ArticleStem cells translational medicine2019

A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer.

Michael T Schweizer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.